| # | Title | Journal | Year | Citations |
|---|
| 1 | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement | Journal of Hepatology | 2020 | 2,171 |
| 2 | 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management | Journal of Crohn's and Colitis | 2017 | 1,547 |
| 3 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | Autophagy | 2021 | 1,430 |
| 4 | Mitochondrial Glutathione, a Key Survival Antioxidant | Antioxidants and Redox Signaling | 2009 | 777 |
| 5 | ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment | Journal of Crohn's and Colitis | 2020 | 741 |
| 6 | Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features | Gastroenterology | 2017 | 650 |
| 7 | Peptic ulcer disease | Lancet, The | 2017 | 570 |
| 8 | 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations | Journal of Crohn's and Colitis | 2017 | 558 |
| 9 | Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery | Annals of Surgery | 2018 | 558 |
| 10 | ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment | Journal of Crohn's and Colitis | 2020 | 478 |
| 11 | Esophageal motility disorders on high‐resolution manometry: Chicago classification version 4.0© | Neurogastroenterology and Motility | 2021 | 468 |
| 12 | An update on the use and investigation of probiotics in health and disease | Gut | 2013 | 448 |
| 13 | Hepatic ischemia and reperfusion injury: Effects on the liver sinusoidal milieu | Journal of Hepatology | 2013 | 447 |
| 14 | Bile acids: Chemistry, physiology, and pathophysiology | World Journal of Gastroenterology | 2009 | 427 |
| 15 | European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases | Journal of Crohn's and Colitis | 2015 | 425 |
| 16 | ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1 | Oncogene | 2010 | 406 |
| 17 | Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial | Lancet Infectious Diseases, The | 2016 | 402 |
| 18 | Outcomes of Treatment for Achalasia Depend on Manometric Subtype | Gastroenterology | 2013 | 387 |
| 19 | Comparative Validation of Polyp Detection Methods in Video Colonoscopy: Results From the MICCAI 2015 Endoscopic Vision Challenge | IEEE Transactions on Medical Imaging | 2017 | 297 |
| 20 | Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial | Lancet Infectious Diseases, The | 2017 | 297 |
| 21 | The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology | Journal of Hepatology | 2020 | 282 |
| 22 | Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) | Gut | 2016 | 274 |
| 23 | Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial | Journal of Hepatology | 2018 | 270 |
| 24 | Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients | Hepatology | 2013 | 269 |
| 25 | Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial | Hepatology | 2008 | 266 |
| 26 | Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2020 | Endoscopy | 2020 | 255 |
| 27 | Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study | Hepatology | 2016 | 251 |
| 28 | Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT’ Study | American Journal of Transplantation | 2009 | 250 |
| 29 | Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease | Cell | 2010 | 243 |
| 30 | Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis | Frontiers in Oncology | 2018 | 243 |
| 31 | Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF | Journal of Hepatology | 2020 | 223 |
| 32 | Systemic treatment of hepatocellular carcinoma: An EASL position paper | Journal of Hepatology | 2021 | 217 |
| 33 | Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants | Clinical Gastroenterology and Hepatology | 2015 | 207 |
| 34 | Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation | Hepatology | 2015 | 206 |
| 35 | Up-regulation of microRNA 506 leads to decreased Cl−/HCO3− anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis | Hepatology | 2012 | 199 |
| 36 | Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs | Gastroenterology | 2011 | 195 |
| 37 | Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation | Journal of Clinical Investigation | 2012 | 183 |
| 38 | Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial | Hepatology | 2016 | 174 |
| 39 | Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation | American Journal of Transplantation | 2012 | 173 |
| 40 | Clinical presentation, diagnosis and staging of cholangiocarcinoma | Liver International | 2019 | 171 |
| 41 | ECCO position statement: The use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD) | Journal of Crohn's and Colitis | 2013 | 169 |
| 42 | Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks | BMC Medicine | 2015 | 165 |
| 43 | A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer | PLoS ONE | 2012 | 164 |
| 44 | Anemia and inflammatory bowel diseases | World Journal of Gastroenterology | 2009 | 162 |
| 45 | Mitochondrial glutathione: Features, regulation and role in disease | Biochimica Et Biophysica Acta - General Subjects | 2013 | 160 |
| 46 | Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma | Gastroenterology | 2019 | 160 |
| 47 | Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection | Hepatology | 2018 | 158 |
| 48 | Redox Control of Liver Function in Health and Disease | Antioxidants and Redox Signaling | 2010 | 155 |
| 49 | FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis | Journal of Hepatology | 2019 | 153 |
| 50 | Role of liver sinusoidal endothelial cells in liver diseases | Nature Reviews Gastroenterology and Hepatology | 2021 | 150 |
